Rachel M. Gittelman

Statistics

Publications

Citations

3.1K

H-Index

Active since

2011

Affiliations

Adaptive Biotechnologies (United States)(Current)

University of Washington

Microsoft (United States)

Fred Hutch Cancer Center

National Institute of Allergy and Infectious Diseases

Rachel M. Gittelman is an author at Adaptive Biotechnologies (United States) specializing in life sciences, immunology, and t-cell repertoire analysis.

ORCID

Publications per year

2011–2025

Publications

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 855 citations

Medicine, Immunology, Oncology +14

Excavating Neandertal and Denisovan DNA from the genomes of Melanesian individuals

Benjamin Vernot, Serena Tucci, Janet Kelso et al. · Science · 2016 · 498 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence

Alexandre Reuben, Rachel M. Gittelman, Jianjun Gao et al. · Cancer Discovery · 2017 · 236 citations · Full text

Medicine, Immunology, Oncology +17

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

Thomas M. Snyder, Rachel M. Gittelman, Mark Klinger et al. · medRxiv · 2020 · 233 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Comprehensive T cell repertoire characterization of non-small cell lung cancer

Alexandre Reuben, Jiexin Zhang, Shin‐Heng Chiou et al. · Nature Communications · 2020 · 229 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 24